Progress in Mind Portugal Your Psychiatry & Neurology Resource Center COVID-19 Learn more ECNP 21 Learn more Medical education resource center Do you want to learn more? Medical education resource center The Lundbeck Institute Campus – the medical education resource center in psychiatry and neurology. Learn More THINC® Focus on cognitive symptoms in depression See More Recent News AllDepressionMigraineSchizophrenia Depression 12 May, 2023 Read Time: 1 min Product Interview Que experiência têm os profissionais de saúde com a utilização da dose de 20 mg de Brintellix® para tratar os seus doentes com TDM? Saiba mais sobre a experiência do Professor Andrea Fagiolini com a dose de 20 mg no webinar que se... Depression 30 Oct, 2022 Read Time: 3 mins Congress highlights Article Highlights in depression research from APA Online 2022 Recent research findings in depression from the poster session at APA Online 2022 covered topics... Depression, Schizophrenia 18 Oct, 2022 Read Time: 5 mins Article Strategies for precision prescribing in psychiatry In a symposium at CINP 2022 entitled ‘Strategies for Precision Prescribing in Psychiatry,’ Prof... Mental Health 04 Oct, 2022 Read Time: 4 mins Congress highlights Article Benefits of measurement-based care in psychiatry Dr Erik Vanderlip (Oregon Health & Science University, USA) was involved in forming the Workgroup... Alzheimer's Disease, Parkinson's Disease 20 Sep, 2022 Read Time: 3 mins Congress highlights Article Will artificial intelligence replace or augment physicians? Artificial intelligence (AI) is already disrupting healthcare in many areas. Will it eventually... Migraine 19 Sep, 2022 Read Time: 3 mins Satellite symposium Article Assessing patient disability is vital for successful treatment of migraine When measuring the success of migraine treatment, it is easy to focus on clinical features like... Migraine 15 Sep, 2022 Read Time: 3 mins Satellite symposium Article Anti-CGRP monoclonal antibody therapy for migraine prevention in the real world Long-term clinical studies and real-world evidence are providing supportive data on the efficacy,... Migraine 14 Sep, 2022 How migraine can impact a person’s life when they are experiencing a migraine attack Professor Cristina Tassorelli sat down with us at EAN 2022 to introduce herself and discuss how... Migraine 13 Sep, 2022 Read Time: 5 mins Satellite symposium Article Experts’ perspectives on managing chronic migraine in their own clinical practice Three experts from different countries provided perspectives on their own clinical practice managing... Migraine 12 Sep, 2022 Read Time: 3 mins Congress highlights Article Raising the healthcare prioritization of headache: Why and how? Headache is the most common neurologic disorder but the least acknowledged, said Professor Rigmor... Migraine 12 Sep, 2022 Read Time: 4 mins Satellite symposium Article New real-world data on the use of calcitonin gene-related peptide monoclonal antibodies for migraine prevention New real-world data on the effectiveness, tolerability, and other benefits of migraine prevention... Schizophrenia 07 Sep, 2022 Read Time: 3 mins Congress highlights Article Interventions to improve real-life functioning Accurate assessment of neurocognition and social cognition and personalized cognitive training and... Migraine 30 Aug, 2022 Read Time: 3 mins Satellite symposium Article What can be done to lower the economic cost of migraine? The annual economic cost of migraine is high — estimated to be €50–111 billion in Europe in 2011.... Mental Health 24 Aug, 2022 Read Time: 3 mins Congress highlights Article How do psychiatric comorbidities affect migraine and its treatment? Patients with migraine often have psychiatric comorbidities. This can affect disease severity and... Migraine 21 Jul, 2022 Read Time: 3 mins Congress highlights Article Migraine research poster highlights from AAN Virtual 2022 Highlights of latest migraine research from the AAN Virtual 2022 poster session included use of... Migraine 18 Jul, 2022 Read Time: 6 mins Satellite symposium Article How to address the full impact of migraine In this symposium held at the 8th Congress of the European Academy of Neurology, Vienna, June 24−28... Migraine 01 Jul, 2022 Read Time: 4 mins Satellite symposium Article Raising the bar for successful migraine prevention A 75% reduction in migraine days can be achieved in up to one-third of patients with chronic migraine... Migraine 30 Jun, 2022 Read Time: 3 mins Congress highlights Article Do US Emergency Departments Use Recommended Migraine Treatments? Millions of patients visit emergency departments (EDs) every year due to headaches, but how good is... Mental Health 28 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 4 — June 28th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Mental Health 27 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 3 — June 27th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Mental Health 26 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 2 — June 26th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Migraine, Parkinson's Disease 26 Jun, 2022 Read Time: 3 mins Congress highlights Article Highlights from EAN 2022 — Day 1 — June 25th Welcome to Progress in Mind’s live coverage of EAN 2022. This 8th Congress of the European Academy of... Migraine 14 Jun, 2022 Read Time: 3 mins Satellite symposium Article The spectrum of medication overuse headache risk factors and treatments What makes migraine worse? A plenary session at the AHS hybrid meeting 2022 addressed exactly this... Alzheimer's Disease 05 Jun, 2022 Read Time: 3 mins Congress highlights Article Targeting tau – homing-in on effective therapies in Alzheimer’s disease Several new and highly promising therapeutics for the management and possible prevention of... Schizophrenia 25 May, 2022 Read Time: 3 mins Congress highlights What is happening in the brain during schizophrenia? Neuroimaging reveals loss of brain gray matter volume in schizophrenia. New insights into the... Migraine 26 Apr, 2022 Read Time: 4 mins Satellite symposium Article Getting a head start on Migraine Prevention Migraine prevention is important to patients and clinicians. A recent Consensus Statement on... Migraine 21 Apr, 2022 Read Time: 2 mins Congress highlights New insights from a poster at IHC2021 on how patients respond when switched from one anti-CGRP monoclonal antibody to another What is the effect of switching to a second anti-CGRP monoclonal antibody when migraine fails to... Migraine 19 Apr, 2022 Read Time: 3 mins Congress highlights New disease-specific treatments for migraine prevention Preventive migraine treatment has been fundamentally changed by the development of treatments... Migraine 07 Mar, 2022 Read Time: 2 mins Satellite symposium Article What do migraine and gut disorders have in common? Nausea, vomiting, and delayed gastric emptying are symptoms of migraine and certain disorders of... Depression 07 Mar, 2022 Read Time: 3 mins Satellite symposium What’s happening in the brain in major depressive disorder? Many different combinations of symptoms lead to a diagnosis of depression, and the many different... Mental Health 03 Mar, 2022 Read Time: 3 mins Congress highlights Current practice with e-mental health and future standards E-mental health is the future for improved mental health delivery at all stages of the patient... PTSD, Depression 28 Feb, 2022 Read Time: 3 mins Congress highlights Where and how are fear memories stored in the brain? When we experience fear, what happens to the memory of the fear in our brain? What happens in our... Parkinson's Disease 22 Feb, 2022 Read Time: 2 mins Congress highlights The link between restless nights and Parkinson’s disease Rapid eye movement sleep behavior disorder is characterized by abnormal sounds and movements during... Schizophrenia 18 Feb, 2022 Read Time: 3 mins Congress highlights Article New 2021 guidelines for the treatment of schizophrenia are now available in Japan The new evidence-based guidelines for the pharmacological therapy of schizophrenia from the Japanese... Parkinson's Disease 17 Feb, 2022 Read Time: 3 mins Congress highlights Will artificial intelligence outperform clinical judgement in the near future? A thought-provoking final debate closed MDS Virtual Congress 2020. The motion—Will artificial... Migraine 15 Feb, 2022 Read Time: 3 mins Congress highlights Focus on general migraine burden and during pregnancy in Arab countries During a regional symposium of the Pan-Arab Union of Neurological Societies (PAUNS) held at #WCN2021,... Schizophrenia 14 Feb, 2022 Read Time: 2 mins Congress highlights Can we predict the future of patients with early-episode psychosis? The ability to better predict patient outcomes would be highly valuable to clinicians, allowing the... Depression 10 Feb, 2022 Read Time: 4 mins Satellite symposium The metabolic interplay between motivation, anxiety and depression There are major differences in individuals’ motivated behaviour and stress coping responses. Genetic... Migraine 09 Feb, 2022 Read Time: 2 mins Congress highlights New insights from posters at IHC2021 — migraine and body mass index and the everyday burden of migraine What is the relationship between high body mass index and migraine? and What is the real-world burden... Schizophrenia 08 Feb, 2022 Read Time: 4 mins Satellite symposium Long-acting therapies could reduce schizophrenia relapse Relapse in schizophrenia contributes to a downward spiral in disease progression. The likelihood of... Migraine 07 Feb, 2022 Read Time: 2 mins Congress highlights Is communication between meningeal immune cells and neurons a critical factor in migraine? How might meningeal immune cells influence neural activity and lead to the symptoms of migraine?... Migraine 30 Dec, 2021 Read Time: 2 mins Congress highlights Impact of abuse on migraine symptoms and comorbidity Emotional, physical, and sexual abuse are associated with an increased risk for developing migraine.... Migraine 16 Dec, 2021 Read Time: 3 mins Satellite symposium What happens in the brain and meninges during a migraine attack? Understanding the relationships between brain activation and migraine symptoms is fundamental to... Schizophrenia 06 Dec, 2021 Read Time: 4 mins Satellite symposium The COVID-19 pandemic and mental health - impact and implications One of the goals of the European College of Neuropsychopharmacology (ECNP) is to facilitate the... Migraine 06 Dec, 2021 Read Time: 3 mins Congress highlights New insights from posters at IHC2021 on how COVID-19 tests and lockdowns have affected patients with migraine Does a nasopharyngeal swab for COVID-19 trigger migraine and what has been the impact of COVID-19... Depression, Schizophrenia 02 Dec, 2021 Read Time: 5 mins Satellite symposium Exploring life engagement in major depressive disorder (MDD) and schizophrenia – mechanisms, measurement, and meaning Functional recovery is a key goal in treatment of major depressive disorder and schizophrenia. In an... Migraine 01 Dec, 2021 Read Time: 4 mins Congress highlights The omics and migraine The omics — genomics, epigenomics, pharmacogenomics, proteomics and metabolomics — are increasing... Depression 17 Nov, 2021 Read Time: 2 mins Congress highlights Melancholic MDD: different presentation and treatment but same response Even if melancholic features represent more severe depression, clinicians seem to have developed... Migraine 15 Nov, 2021 Read Time: 2 mins Congress highlights New insights from a poster at IHC2021 on the depiction of migraine in the media How realistic is the presentation of migraine in the media? Does it help raise awareness and lessen... Migraine 11 Nov, 2021 Read Time: 3 mins Congress highlights Insights into migraine mechanisms: a central brain disorder with peripheral inputs Speaking at #WCN2021, Professor Todd Schwedt, of the Mayo Clinic, USA summarized that although there... Depression 09 Nov, 2021 Read Time: 3 mins Congress highlights Could lactate and L-acetylcarnitine lead us to new drug targets? Drugs based on epigenetic and metabolic mechanisms that influence glutamatergic function and... Mental Health 05 Nov, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 1 — October 2nd Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Mental Health 05 Nov, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 4 — October 5th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Mental Health 05 Nov, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 3 — October 4th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Mental Health 05 Nov, 2021 Read Time: 4 mins Congress highlights Highlights from ECNP 2021 — Day 2 — October 3rd Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Bipolar 29 Oct, 2021 Read Time: 3 mins Congress highlights New evidence on brain structure linked to polarity Predominant depressive polarity is associated with reduced cortical thickness and smaller hippocampal... Migraine 29 Oct, 2021 Read Time: 4 mins Congress highlights Do anti-CGRP monoclonal antibodies alter the expected course of migraine? Are anti-CGRP monoclonal antibodies disease modifying therapies for migraine? Do they alter the... Bipolar, Schizophrenia 26 Oct, 2021 Read Time: 2 mins Congress highlights Do similar polygenic risk factors for schizophrenia apply across ethnic groups? Polygenic risk factors for schizophrenia and bipolar disorder-- and the genetic factors that... Migraine 14 Oct, 2021 Read Time: 3 mins Satellite symposium New migraine preventives: which patients will benefit, when, and how? In an interactive symposium at #WCN2021, leading experts discussed practical approaches to managing... Migraine 08 Oct, 2021 Read Time: 3 mins Satellite symposium Experts discuss: how might we prevent migraine disease progression? In a satellite symposium at #WCN2021, three leading experts discussed recent insights into migraine... Schizophrenia 04 Oct, 2021 Read Time: 4 mins Satellite symposium Small steps for big impact in treatment of schizophrenia Functional recovery is an important goal in treating schizophrenia, but one that can be hard to... Mental Health 02 Oct, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 4 — October 5th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Schizophrenia 02 Oct, 2021 Read Time: 4 mins Satellite symposium Bridging treatment adherence to functional recovery in schizophrenia Non-adherence to treatment is a key issue in people with schizophrenia and can hold back response,... Migraine 13 Sep, 2021 Read Time: 3 mins Satellite symposium Anti-CGRP monoclonal antibodies in the real world When are anti-CGRP monoclonal antibodies used for migraine in the real world, how effective are they,... Schizophrenia 13 Sep, 2021 Read Time: 3 mins Congress highlights Cytokine dysregulation in schizophrenia Studies continue to indicate a multifaceted relationship between immunological and inflammatory... Migraine 10 Sep, 2021 Read Time: 3 mins Congress highlights Is precision medicine possible in migraine? Is precision medicine possible in migraine? This was the subject of an entertaining debate at... Migraine 09 Sep, 2021 Read Time: 3 mins Satellite symposium Expert insights into medication overuse headache Medication overuse headache is common, but much is still not clear about its precise prevalence among... Migraine 23 Aug, 2021 Read Time: 3 mins Satellite symposium Are new migraine preventive therapies meeting unmet needs? Improved efficacy, tolerability, adherence, and quality of life and lowered total pain burden are all... Migraine 16 Aug, 2021 Read Time: 3 mins Congress highlights Insights into migraine pathology, progression, and treatment Professor Paul Durham, Missouri State University, speaking during the Hot Topics in Basic Science... Mental Health 10 Aug, 2021 Read Time: 3 mins Congress highlights Pandemic requires comprehensive approach to mental health in the elderly Existing psychiatric problems such as depression and anxiety in the elderly should not be forgotten... Migraine 09 Aug, 2021 Read Time: 3 mins Congress highlights Does migraine alter COVID-19 susceptibility? In a late-breaking abstract presentation at #AHSAM21, Professor Robert Shapiro, University of... Schizophrenia 30 Jul, 2021 Read Time: 4 mins Congress highlights From clinic to community – insights on successful early psychosis management programs In the USA, OnTrackNY and the Early Psychosis Intervention NETwork (EPINET) are different parts of a... Load More Depression, Schizophrenia 09 Aug, 2019 Video #3: Shared decision-making and therapeutic alliance in schizophrenia Depression 04 Jun, 2019 Read Time: 4 mins Satellite symposium Treatment outcomes that matter – established and emerging therapies for patients with major depressive disorder who do not respond adequately to antidepressants Major depressive disorder (MDD) has significant costs to society and is predicted to be the leading... Depression 04 Jun, 2019 Read Time: 4 mins Congress highlights Immune modulation in psychiatric disorders: Are we there yet? It has been argued that drug discovery for psychiatric disorders is at a near standstill. Which... Mental Health 21 May, 2019 Read Time: 3 mins Congress highlights What is the role of inflammation in the pathophysiology of mood disorders? Evidence supporting a role for inflammation and pro-inflammatory mediators in the pathophysiology and... Mental Health 21 May, 2019 Read Time: 3 mins Congress highlights A public invitation to view and comment on pre-final APA schizophrenia guideline statements Many guidelines exist worldwide on how best to manage psychiatric illnesses, but we never see two... Mental Health 14 May, 2019 Read Time: 3 mins Congress highlights Challenges for social psychiatry in a changing world Modern social risk factors for the development of severe psychiatric disorders, such as migration and... Depression, Schizophrenia 13 May, 2019 Read Time: 5 mins Congress highlights Lifestyle, the gut, and mental health Interventions to lower the risk for cardiovascular disease and metabolic syndrome, correction of... Mental Health 09 May, 2019 Read Time: 4 mins Congress highlights Social isolation and stigma: Cross-cultural perspectives Meaningful connection to other people is as essential to health as the air we breathe. So the stigma... Load More Migraine 09 Aug, 2021 Read Time: 3 mins Congress highlights Does migraine alter COVID-19 susceptibility? In a late-breaking abstract presentation at #AHSAM21, Professor Robert Shapiro, University of... Migraine 26 Jul, 2021 Read Time: 3 mins Congress highlights Preventive treatment gaps and priorities in migraine Speaking at #ASHAM21, Dr Stephanie Nahas, Thomas Jefferson University, identified that only a... Migraine 21 Jul, 2021 Read Time: 3 mins Congress highlights COVID-19 vaccines, migraine, and preventives: any evidence of interactions? The advent of COVID-19 vaccines has raised questions on whether vaccines impact on the management of... Migraine 05 Jul, 2021 Read Time: 2 mins Congress highlights CGRP has a role in infection-induced pain While the role of calcitonin gene-related peptide (CGRP) in headache and migraine is well... Migraine, Alzheimer's Disease 22 Jun, 2021 Read Time: 2 mins Congress highlights Highlights from EAN 2021 — Day 4 Today, 22 June, Day 4 of the 7th Congress of the European Academy of Neurology – Vienna... Migraine, Alzheimer's Disease 21 Jun, 2021 Read Time: 2 mins Congress highlights Highlights from EAN 2021 — Day 3 Progress in Mind’s coverage of the 7th Congress of the European Academy of Neurology – Vienna 2021... Migraine 20 Jun, 2021 Read Time: 4 mins Satellite symposium Migraine management conundrums—the data can help What is the best management for patients with migraine if they have cardiovascular disease or if they... Migraine 20 Jun, 2021 Read Time: 4 mins Congress highlights Real world evidence for CGRP antibodies in migraine prevention In a topical symposium at #EAN2021, three speakers discussed what is new on targeting CGRP for... Load More Schizophrenia 16 Apr, 2020 Read Time: 3 mins Article Pandemic brings challenge and opportunity for people with schizophrenia The COVID-19 pandemic risks exacerbating symptoms in people prone to experience reality in unusual... Mental Health 06 Apr, 2020 Read Time: 2 mins Article Practical support for mental health in time of crisis Many people with mental health diseases will experience additional emotional distress when faced with... Schizophrenia 23 Mar, 2020 What is Schizophrenia? Depression, Schizophrenia 19 Mar, 2020 Read Time: 2 mins Interview Early intervention services have the potential to improve the success of treatment and social functioning for individuals with schizophrenia Schizophrenia is a heterogenous, progressive and recurrent disease with multiple dimensions which can... Schizophrenia 10 Mar, 2020 Improvement in schizophrenia: Long and short term perspectives Schizophrenia 27 Jan, 2020 Read Time: 3 mins Article The neurobiology of conversion to psychosis – emerging findings from the SHARP study The clinical high risk (CHR) phase of schizophrenia when cognitive and social functioning begin to... Schizophrenia 13 Jan, 2020 Read Time: 0 min Interview John FP Bridges - Changing the paradigm: putting patient treatment goals at the center Schizophrenia 08 Jan, 2020 Read Time: 0 min Interview John FP Bridges - Aiming for recovery: the world before Schizophrenia Load More Most Popular